证券代码：688625 证券简称：呈和科技 公告编号：2023-064 呈和科技股份有限公司（以下简称"公司"）于 2023 年 9 月 5 日召开 2023 年第二次临时 股东大会，选举产生了公司第三届董事会成员，任期自 2023 年第二次临时股东大会审议通过 之日起三年。具体内容详见公司于 2023 年 9 月 6 日在上海证券交易所网站（www.sse.com.cn） 披露的《2023 年第二次临时股东大会决议公告》（2023-063）。 2023 年 9 月 8 日，公司召开第三届董事会第一次会议，审议通过了《关于选举公司第三 届董事会董事长及名誉董事长的议案》《关于选举公司第三届董事会各专门委员会委员及召集 人的议案》《关于聘任公司高级管理人员的议案》《关于聘任公司内审部门负责人的议案》《关 于聘任公司证券事务代表的议案》。现就相关审议情况公告如下: 一、董事会换届选举情况 （一）董事选举情况 2023 年 9 月 5 日，公司召开 2023 年第二次临时股东大会，本次股东大会采用累积投票 制的方式选举赵文林先生、仝佳奇先生、赵文声先生、赵文浩先生为公司第三届董事会非独 立董事，选举叶罗沅先生、燕学 ...

中信证券股份有限公司 关于呈和科技股份有限公司 2023 年半年度持续督导跟踪报告 中信证券股份有限公司（以下简称"中信证券"或"保荐机构"）作为呈和 科技股份有限公司（以下简称"呈和科技"或"公司"）以简易程序向特定对象 发行 A 股股票项目的保荐机构，根据《证券发行上市保荐业务管理办法》、《上 海证券交易所科创板股票上市规则》等相关规定，负责呈和科技的持续督导工作， 并出具本持续督导半年度跟踪报告。 | 序号 | 工作内容 | 持续督导情况 | | --- | --- | --- | | 1 | 建立健全并有效执行持续督导工作制度，并针 | 保荐机构已建立健全并有效 执行了持续督导制度，并制定 | | | 对具体的持续督导工作制定相应的工作计划 | | | | | 了相应的工作计划 | | | 根据中国证监会相关规定，在持续督导工作 | 保荐机构已与呈和科技签订 | | | 开始前，与上市公司或相关当事人签署持续督 | 《保荐协议》，已明确双方在 | | 2 | 导协议，明确双方在持续督导期间的权利义 | 持续督导期间的权利和义务， | | | 务，并报上海证券交易所备案 | 并已报上海证券交易所备案 | ...

北京大成（广州）律师事务所 关于呈和科技股份有限公司 2023 年第二次临时股东大会的 法律意见书 www.dentons.cn 中国广州市珠江新城珠江东路 6 号广州周大福金融中心 14、15 层单元（510623） 14/F,15/F ,CTF Finance Centre, No.6 Zhujiang East Road, Zhujiang New Town, Guangzhou 510623, China Tel： +86 20-85277000 Fax： +86 20-85277002 二零二三年九月 北京大成（广州）律师事务所 关于呈和科技股份有限公司 2023 年第二次临时股东大会的法律意见书 大成证字[2023]第 248 号 致：呈和科技股份有限公司 根据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人民共 和国公司法》（以下简称"《公司法》"）和中国证券监督管理委员会《上市公司 股东大会规则（2022 年修订）》（以下简称"《股东大会规则》"）等法律、法规 和其他有关规范性文件的要求，北京大成（广州）律师事务所（以下简称"本所"） 接受呈和科技股份有限公司（以下简称"公司"）的 ...

证券代码：688625 证券简称：呈和科技 公告编号：2023-063 呈和科技股份有限公司 2023 年第二次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2023 年 9 月 5 日 （二） 股东大会召开的地点：广州市天河区珠江东路 6 号广州周大福金融中心 6501 室 二、 议案审议情况 （一） 非累积投票议案 1、 议案名称：《关于公司 2023 年半年度利润分配预案的议案》 审议结果：通过 表决情况： （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及其持有表决权 数量的情况： | 1、出席会议的股东和代理人人数 | 4 | | --- | --- | | 普通股股东人数 | 4 | | 2、出席会议的股东所持有的表决权数量 | 92,507,200 | | 普通股股东所持有表决权数量 | 92,507,200 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的 ...

呈和科技股份有限公司 2023 年第二次临时股东大会会议资料 证券代码：688625 证券简称：呈和科技 呈和科技股份有限公司 2023 年第二次临时股东大会 会议资料 二零二三年九月 1 / 9 呈和科技股份有限公司 2023 年第二次临时股东大会会议资料 呈和科技股份有限公司 2023 年第二次临时股东大会会议资料目录 | 2023 | | 年第二次临时股东大会会议须知 3 | | | --- | --- | --- | --- | | 2023 | | 年第二次临时股东大会会议议程 5 | | | 2023 | | 年第二次临时股东大会会议议案 7 | | | | 议案 | 1 关于公司 2023 年半年度利润分配预案的议案 | 7 | | | 议案 | 2 关于公司董事会换届选举暨提名第三届董事会非独立董事候选人的议案 8 | | | | 议案 | 3 关于公司董事会换届选举暨提名第三届董事会独立董事候选人的议案 | 9 | 2 / 9 呈和科技股份有限公司 2023 年第二次临时股东大会会议资料 呈和科技股份有限公司 2023 第二次临时股东大会会议须知 为了维护全体股东的合法权益，确保股东大会的正 ...

证券代码：688625 证券简称：呈和科技 公告编号： 2023-062 呈和科技股份有限公司 关于召开 2023 年半年度业绩暨现金分红说明会的公告 三、 参加人员 会议召开时间：2023 年 08 月 30 日(星期三) 下午 16:00-17:00 会议召开地点：上海证券交易所上证路演中心（网址：http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 （二） 会议召开地点：上证路演中心 （三） 会议召开方式：上证路演中心网络互动 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 投资者可于 2023 年 08 月 23 日(星期三) 至 08 月 29 日(星期二)16:00 前登录上证路演 中心网站首页点击"提问预征集"栏目或通过公司邮箱（ir@gchchem.com）进行提问。公司 将在说明会上对投资者普遍关注的问题进行回答。 呈和科技股份有限公司（以下简称"公司"）已于 2023 年 08 月 18 日发布公司《2023 年 年半年度报告》及《关于公司 2 ...

Financial Performance - The company's operating revenue for the first half of 2023 reached ¥369,632,844.55, representing an increase of 11.86% compared to ¥330,438,210.99 in the same period last year [23]. - The net profit attributable to shareholders for the first half of 2023 was ¥108,779,304.66, up 10.59% from ¥98,360,059.35 in the previous year [23]. - The net profit after deducting non-recurring gains and losses increased by 20.08%, amounting to ¥103,244,062.49 compared to ¥85,977,612.96 in the same period last year [23]. - The company's net cash flow from operating activities decreased by 19.52%, totaling ¥85,164,493.59, down from ¥105,819,430.78 in the previous year [23]. - The total assets at the end of the reporting period were ¥2,746,914,816.87, reflecting a 14.94% increase from ¥2,389,783,591.35 at the end of the previous year [23]. - The net assets attributable to shareholders increased by 19.53%, reaching ¥1,263,449,423.61 compared to ¥1,057,028,197.81 at the end of the previous year [23]. - Basic earnings per share for the first half of 2023 were ¥0.81, a 9.46% increase from ¥0.74 in the same period last year [24]. - The company's revenue for the first half of 2023 reached RMB 369.63 million, representing a year-on-year growth of 11.86% [60]. - The net profit attributable to shareholders for the same period was RMB 108.78 million, an increase of 10.59% year-on-year [60]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 103.24 million, reflecting a year-on-year growth of 20.08% [60]. Research and Development - The company increased its R&D investment to ¥15,834,083.43, a 13.13% increase compared to ¥13,996,723.05 in the same period last year [46]. - R&D investment accounted for 4.28% of total revenue, up by 0.04 percentage points from 4.24% in the previous year [46]. - The company holds a total of 56 valid patents, including 49 invention patents and 7 utility model patents, with 5 new invention patent applications filed during the reporting period [45]. - The company has developed several advanced technologies, including a β crystal toughening nucleating agent, which is a first in the industry [43]. - The company has established a long-term technical exchange and cooperation with customers to ensure R&D innovation meets market demand [43]. - The company has introduced advanced experimental analysis and testing instruments to enhance its R&D capabilities [43]. - The company has completed projects on calcium salt toughening nucleating agents and high-gloss low-warp nucleating agents, with total investments of RMB 400 million and RMB 250 million respectively [49]. - The company has developed a new type of sorbitol-based nucleating agent with an investment of RMB 450 million, achieving small-scale trial success and preparing for pilot production [50]. - The company has successfully integrated the R&D and production of special antioxidants through acquisitions, enhancing its product line and market reach [53]. Market and Industry Trends - The high-performance resin and modified plastics industry is experiencing significant growth, with production capacity doubling due to increased demand from downstream sectors like automotive and home appliances [37]. - The domestic market for high-end modified plastics remains reliant on imports, indicating a strong potential for domestic production to meet growing demand [38]. - The nucleating agent market in China has seen an increase in import substitution rate from 19% in 2017 to 28% in 2022, with expectations to reach 34% by 2025 [40]. - The synthetic hydrotalcite market is positioned for growth as it serves as a non-toxic, efficient heat stabilizer for PVC, with increasing regulatory support for green materials [41]. - The antioxidant market is entering a phase of intense competition, driven by rising demand in emerging industries such as new energy vehicles and healthcare services [42]. - The market for modified plastics is expanding into high-tech fields, indicating a broadening application scope and increasing demand for differentiated high-end products [38]. Corporate Governance and Compliance - The report highlights that the company has not faced any non-operating fund occupation by controlling shareholders or related parties [7]. - The board of directors has confirmed the authenticity, accuracy, and completeness of the financial report for the first half of 2023 [4]. - The report indicates that the financial report has not been audited [5]. - The company emphasizes that forward-looking statements do not constitute a commitment to investors [6]. - There are no special arrangements for corporate governance mentioned in the report [6]. - The company has confirmed that there are no violations in decision-making procedures regarding external guarantees [8]. - The report does not indicate any inability of the majority of directors to ensure the report's authenticity and completeness [9]. - The company has not faced any administrative penalties related to environmental issues during the reporting period [111]. - The company has committed to protecting investors' rights and will take necessary measures if it fails to meet its obligations [131]. Environmental Responsibility - The company is committed to green and sustainable development, focusing on low-carbon transformation and the production of environmentally friendly materials [60]. - The company allocated RMB 429.77 million for environmental protection during the reporting period [97]. - The company’s environmental facilities operated effectively, with no penalties from environmental authorities during the reporting period [98]. - The company achieved a pH value of 7.3-7.4 for wastewater discharge, meeting the standard limit of 6.5-9 [99]. - Chemical oxygen demand (COD) in wastewater was recorded at 47 mg/L, below the standard limit of 50 mg/L [99]. - The company has implemented effective pollution control measures, with all monitored pollutants meeting regulatory standards [106]. - The company actively participated in the "Waste-Free Factory" initiative, integrating green low-carbon concepts into the entire industrial production process [112]. - The company adopted clean energy measures, including natural gas and solar street lights, to reduce carbon emissions and promote a low-carbon lifestyle among employees [112]. Shareholder and Stock Management - The company plans to distribute a cash dividend of RMB 6.00 per 10 shares, totaling RMB 81,196,618.80 based on a total share capital of 135,327,698 shares [5]. - The profit distribution proposal is pending approval from the shareholders' meeting [5]. - The company has committed to a continuous and stable profit distribution policy, prioritizing cash dividends, with a minimum of 80% cash dividend allocation for mature companies without major capital expenditure plans [135]. - The company has committed to reducing solid waste through the principles of reduction, resource utilization, and harmless treatment [112]. - The company plans to repurchase shares to stabilize stock prices, ensuring the repurchase price does not exceed the latest audited net asset value per share [120]. - The controlling shareholder's funds for share purchases must be no less than 30% and no more than 50% of their after-tax salary from the previous year [122]. - The company must announce the share repurchase decision within 15 trading days after the triggering conditions are met [124]. - The share repurchase plan must be completed within 30 trading days after the shareholders' meeting resolution [124]. Investment and Acquisitions - The company completed the acquisition of Tangshan Keao Chemical and Tianjin Xindafeng, with a total investment of RMB 10,800 million, of which RMB 8,100 million has been paid as of the reporting period [81]. - The acquisition of 100% equity in Kao Chemical is part of the company's strategy for market expansion, with a committed investment of ¥75,200,000 [153]. - The company has raised and utilized up to RMB 400 million of idle self-owned funds for cash management, with a balance of RMB 78 million as of June 30, 2023 [160]. - The company has utilized ¥158,240,220.22 of idle raised funds for temporary working capital, with a repayment of ¥193,700,220.22 made by April 2023 [157]. Risks and Challenges - The company faces risks related to raw material price increases and supply chain disruptions, which could adversely affect operational performance [68]. - The accounts receivable balance at the end of the reporting period was RMB 193.88 million, representing 52.45% of the current operating income, indicating potential risks related to bad debts [65]. - The company’s overseas revenue amounted to RMB 61.04 million, accounting for 16.51% of total revenue, exposing it to foreign exchange risks [66].

证券代码：688625 证券简称：呈和科技 公告编号：2023-058 呈和科技股份有限公司 第三届监事会第十次会议决议公告 本公司监事会及全体监事成员保证公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 （一）呈和科技股份有限公司（以下简称"公司"）第三届监事会第十次会议的通知及会 议资料已于 2023 年 8 月 5 日以电子邮件、专人发放及电话通知等方式向全体监事、高级管理 人员送达，监事会会议通知包括会议的相关材料，同时列明了会议的召开时间、地点、内容 和方式。 （二）本次会议于 2023 年 8 月 16 日下午在公司会议室召开，采取现场投票的方式进行 表决。本次会议应出席监事三人，实际出席监事三人。会议由监事会主席何洁冰女士主持， 公司全体高级管理人员列席了本次会议。 （三）本次会议的召集和召开程序符合《中华人民共和国公司法》《上海证券交易所科创 板股票上市规则》等相关法律、行政法规、部门规章、规范性文件及《呈和科技股份有限公 司章程》（以下简称"《公司章程》"）的规定，会议决议合法、有效。 具体内容详见公司同日在上 ...

二、本人任职资格符合下列法律、行政法规和部门规章以及公司 规章的要求: (一)《中华人民共和国公司法》等关于董事任职资格的规定; (二)《中华人民共和国公务员法》关于公务员兼任职务的规定 (如适用): 科创板上市公司独立董事候选人声明与承诺 一、本人具备上市公司运作的基本知识,熟悉相关法律、行政法 规、部门规章及其他规范性文件,具有五年以上法律、经济会计、财 务、管理等履行独立董事职责所必需的工作经验。 (三)中国证监会《上市公司独立董事管理办法》和上海证券交 易所自律监管规则有关独立董事任职资格和条件的相关规定; 本人燕学善,已充分了解并同意由提名人呈和科技股份有限公司 董事会提名为呈和科技股份有限公司第三届董事会独立董事候选人。 本人公开声明,本人具备独立董事任职资格,保证不存在任何影响本 人担任呈和科技股份有限公司独立董事独立性的关系,具体声明并承 诺如下: (四)中共中央纪委、中共中央组织部《关于规范中管干部辞去 公职或者退（离）休后担任上市公司、基金管理公司独立董事、独立 监事的通知》的规定(如适用); (五)中共中央组织部《关于进一步规范党政领导干部在企业兼 职（任职）问题的意见》的相关规定(如适 ...

科创板上市公司独立董事候选人声明与承诺 本人阙占文,已充分了解并同意由提名人呈和科技股份有限公司 董事会提名为呈和科技股份有限公司第三届董事会独立董事候选人。 本人公开声明,本人具备独立董事任职资格,保证不存在任何影响本 人担任皇和科技股份有限公司独立董事独立性的关系,具体声明并承 诺如下: 一、本人具备上市公司运作的基本知识,熟悉相关法律、行政法 规、部门规章及其他规范性文件,具有五年以上法律、经济会计、财 务、管理等履行独立董事职责所必需的工作经验。 二、本人任职资格符合下列法律、行政法规和部门规章以及公司 规章的要求: (一)《中华人民共和国公司法》等关于董事任职资格的规定; (二)《中华人民共和国公务员法》关于公务员兼任职务的规定 (如适用): (三)中国证监会《上市公司独立董事管理办法》和上海证券交 易所自律监管规则有关独立董事任职资格和条件的相关规定; (四)中共中央纪委、中共中央组织部《关于规范中管干部辞去 公职或者退(离)休后担任上市公司、基金管理公司独立董事、独立 监事的通知》的规定(如适用); (五)中共中央组织部《关于进一步规范党政领导干部在企业兼 职 (任职) 问题的意见》的相关规定 ...